Trials / Completed
CompletedNCT01337596
A Study of LY2951742 in Healthy Volunteers
A Safety, Tolerability, and Pharmacokinetic Study of Single, Escalating Subcutaneous Doses of LY2951742 in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 63 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the safety and tolerability of LY2951742 given as single or multiple subcutaneous injection in healthy male subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LY2951742 | Administered subcutaneously |
| DRUG | Placebo | Administered subcutaneously |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2012-04-01
- Completion
- 2012-04-01
- First posted
- 2011-04-19
- Last updated
- 2019-02-20
- Results posted
- 2019-02-20
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT01337596. Inclusion in this directory is not an endorsement.